Chemycal has been acquired by 3E
Learn MoreChemycal has been acquired by 3E
Learn More
Discover how Chemycal PRO helps you boosting your regulatory monitoring:
Today, the U.S. Food and Drug Administration issued the final guidance, “Breast Implants - Certain Labeling Recommendations to Improve Patient Communication,” as part of the agency’s effort to help improve the information available to patients and health care professionals about the risks of breast implants. The draft guidance of this document was issued in 2019.
CONTINUE READING ON www.fda.gov
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions
